Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Verify your 2026 benefits: During open enrollment, confirm whether your employer plan will cover Zepbound next year Consider plan switching: If your current plan is dropping coverage, evaluate other options during open enrollment Medicare patients: Monitor CMS.gov for any Medicare coverage policy changes
"Tirzepatide Once Weekly for the Treatment of Obesity." NEJM 2022 (SURMOUNT-1) ClinicalTrials.gov: TRIUMPH Phase 3 program trial protocols and status updates FDA Prescribing Information: Wegovy, Mounjaro/Zepbound, Saxenda (for comparative safety data) Frequently Asked Questions Most side effects peak during dose escalation (weeks 412) and improve substantially by week 24
Viruses 14, 950
Unsure what treatment is right for you
US$ 27.55
US$ 20.14
US$ 21.33
